Skip to main content

Peer Review reports

From: Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group)

Original Submission
22 Sep 2022 Submitted Original manuscript
2 Dec 2022 Author responded Author comments - Fiona Day
Resubmission - Version 2
2 Dec 2022 Submitted Manuscript version 2
Publishing
5 Dec 2022 Editorially accepted
17 Dec 2022 Article published 10.1186/s12885-022-10407-8

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us